Inefficient Induction of Neutralizing Antibodies against SARS-CoV-2 Variants in Patients with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy after Receiving a Third mRNA Vaccine Dose
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
To evaluate the humoral response of SARS-CoV-2 variants in patients with IBD 60 days after receiving the third dose of mRNA COVID-19 vaccine.
创建时间：
2025-10-30
